Cyclica Inc. is awarded access to IBM’s Blue Gene supercomputer to repurpose FDA approved drugs

TORONTO, Canada – July 2, 2013 – Cyclica Inc. has been awarded access to IBM’s Blue Gene supercomputer to optimize drug discovery and development using existing drugs that have been identified as having repurposing potential. The project will leverage Cyclica’s data platform, as well as some simulation software packages developed by Modecular. Cyclica’s co-founder, Mickaël… Continue reading Cyclica Inc. is awarded access to IBM’s Blue Gene supercomputer to repurpose FDA approved drugs

RIC Client Intronix Technologies Corp. recieves FDA Clearance for MyoGuide™

TORONTO, March 30, 2012 Reposted from Bloomberg Businessweek Great things come in small packages, or at least that’s what leading neurologists, physiatrists and clinicians are now discovering with the revolutionary Myoguide Needle EMG Guided Injection System. The breakthrough technology, which has just received 510(k) clearance from the United States Food and Drug Administration, gives practitioners… Continue reading RIC Client Intronix Technologies Corp. recieves FDA Clearance for MyoGuide™